Sarah Bocchini

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial

Soraya Allas, Assumpta Caixàs, Christine Poitou et al. · PLoS ONE · 2018 · 97 citations · Full text

Agriculture, Pharmacology, Pharmacotherapy +13

Disorders of glucose metabolism in Prader–Willi syndrome: Results of a multicenter Italian cohort study

Danilo Fintini, Graziano Grugni, Sarah Bocchini et al. · Nutrition Metabolism and Cardiovascular Diseases · 2016 · 67 citations

Life Sciences, Biochemistry, Endocrinology +15

Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues

Salvatore Ulisse, Enke Baldini, Matteo Toller et al. · Endocrine Related Cancer · 2007 · 53 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Use of GLP-1 Receptor Agonists in Prader-Willi Syndrome: Report of Six Cases

Danilo Fintini, Graziano Grugni, Claudia Brufani et al. · Diabetes Care · 2014 · 41 citations

Medicine, Endocrinology, Pharmacology +17

Growth Hormone Response to Standard Provocative Stimuli and Combined Tests in Very Young Children with Prader-Willi Syndrome

Girolamo Di Giorgio, Graziano Grugni, Danilo Fintini et al. · Hormone Research in Paediatrics · 2014 · 24 citations

Medicine, Endocrinology, Pediatrics +15